Fasenra

Fasenra Caution For Usage

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Caution For Usage
Incompatibilities: In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.
Instructions for use, handling and disposal: Do not shake. Do not use if frozen.
Prior to administration, warm FASENRA by leaving carton at room temperature. This generally takes 30 minutes.
Visually inspect FASENRA for particulate matter and discoloration prior to administration. FASENRA is clear, colourless to yellow, and may contain translucent or white to off-white particles. Do not use FASENRA if liquid is cloudy, discoloured, or if it contains large particles or foreign particulate matter.
Additional information and instructions for the preparation and administration of FASENRA using the prefilled syringe are given in the package leaflet and 'Instruction for use' under Patient Counselling Information.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in